What is Avery Dennison Corp.'s earnings per share (EPS)?

Avery Dennison Corp. (AVY) reported diluted earnings per share of $8.79 for fiscal year 2025. This represents a 0.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Avery Dennison Corp. (AVY) Financials

AVY

Trailing 12 months to June 30, 2026

Revenue $9.2B +5.8% YoY

Net Income $704.9M -0.9% YoY

EPS (Diluted) $9.13 +2.4% YoY

Free Cash Flow $1.1B +67.3% YoY

Market Cap $12.7B as of Oct 10, 2026

Price / Sales 1.4x on $9.2B revenue, trailing 12 months to June 30, 2026

Price / Earnings 18.0x on $704.9M net income, trailing 12 months to June 30, 2026

Price / Book 5.5x on $2.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AVY SEC filings page.

Avery Dennison Corp. (AVY) reported $9.2B in revenue over the twelve months to Jun 30, 2026, up 5.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AVY FY2025 2026-10-04

Avery Dennison converts profits into cash, but 2025 shareholder payouts and higher debt absorbed more than free cash flow.

Gross margin held at 28.8% in 2025, while net margin eased to 7.8%. That divergence indicates pressure below production costs, consistent with interest expense rising to $135M as debt increased to $3.2B.

Operating cash flow of $881M exceeded net income of $688M, so non-cash charges and working-capital movements more than bridged accounting earnings to cash. But free cash flow fell to $712M, showing reinvestment consumed part of that conversion.

Share repurchases and dividends totaled $861M in 2025, exceeding free cash flow of $712M. Debt-to-equity rose to 1.4x in FY2025, while short-term coverage improved to 1.1x, indicating distributions were supported alongside greater balance-sheet leverage.

Financial Health Signals

Financial Health Score 27/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Avery Dennison Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Avery Dennison Corp., and counted as zero in the overall score.

Growth

Avery Dennison Corp.'s revenue grew a modest 1.1% year-over-year to $8.9B. This slow but positive growth earns a score of 41/100.

Leverage

Avery Dennison Corp. has a moderate D/E ratio of 1.43. This balance of debt and equity financing earns a leverage score of 39/100.

Liquidity

Avery Dennison Corp.'s current ratio of 1.13 is below the typical benchmark, resulting in a score of 25/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Avery Dennison Corp. has a free cash flow margin of 8.0%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Avery Dennison Corp., and counted as zero in the overall score.

Piotroski F-Score Neutral

5/9

Avery Dennison Corp. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.28x

For every $1 of reported earnings, Avery Dennison Corp. generates $1.28 in operating cash flow ($881.4M OCF vs $688.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5B

YoY+10.9%

QoQ+7.2%

5Y CAGR+4.3%

10Y CAGR+5.0%

Avery Dennison Corp. generated $2.5B in revenue in Q2 2026. This represents an increase of 10.9% from the same quarter a year earlier. Against the prior quarter it is up 7.2%.

Net Income

$204.1M

YoY+8.0%

QoQ+21.4%

5Y CAGR+1.3%

10Y CAGR+12.3%

Avery Dennison Corp. reported $204.1M in net income in Q2 2026. This represents an increase of 8.0% from the same quarter a year earlier. Against the prior quarter it is up 21.4%.

EPS (Diluted)

$2.67

YoY+10.8%

QoQ+22.5%

5Y CAGR+3.2%

10Y CAGR+14.7%

Avery Dennison Corp. earned $2.67 per diluted share (EPS) in Q2 2026. This represents an increase of 10.8% from the same quarter a year earlier. Against the prior quarter it is up 22.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$369.0M

YoY+106.4%

QoQ+241.0%

5Y CAGR+13.1%

10Y CAGR+10.6%

Avery Dennison Corp. generated $369.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 106.4% from the same quarter a year earlier. Against the prior quarter it is up 241.0%.

Cash & Debt

$227.3M

YoY+5.3%

QoQ-10.9%

5Y CAGR-2.1%

10Y CAGR+0.1%

Avery Dennison Corp. held $227.3M in cash against $3.2B in long-term debt as of Q2 2026.

Dividends Per Share

$1.00

YoY+6.4%

QoQ+6.4%

5Y CAGR+10.0%

10Y CAGR+10.5%

Avery Dennison Corp. paid $1.00 per share in dividends in Q2 2026. This represents an increase of 6.4% from the same quarter a year earlier. Against the prior quarter it is up 6.4%.

Shares Outstanding

76M

YoY-2.8%

QoQ-0.9%

5Y CAGR-1.8%

10Y CAGR-1.9%

Avery Dennison Corp. had 76M shares outstanding in Q2 2026. This represents a decrease of 2.8% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Margins & Returns

Gross Margin

29.6%

YoY+0.8pp

QoQ+0.7pp

5Y change+0.9pp

10Y change+2.1pp

Avery Dennison Corp.'s gross margin was 29.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Net Margin

8.3%

YoY-0.2pp

QoQ+1.0pp

5Y change-1.3pp

10Y change+4.1pp

Avery Dennison Corp.'s net profit margin was 8.3% in Q2 2026, showing the share of revenue converted to profit. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.

Return on Equity

8.8%

YoY+0.2pp

QoQ+1.5pp

5Y change-4.1pp

10Y change+3.0pp

Avery Dennison Corp.'s ROE was 8.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$137.6M

YoY+39.8%

QoQ+127.1%

5Y CAGR+21.4%

10Y CAGR+17.4%

Avery Dennison Corp. spent $137.6M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 39.8% from the same quarter a year earlier. Against the prior quarter it is up 127.1%.

Capital Expenditures

$39.2M

YoY+30.7%

QoQ+38.5%

5Y CAGR-18.6%

10Y CAGR+2.3%

Avery Dennison Corp. invested $39.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 30.7% from the same quarter a year earlier. Against the prior quarter it is up 38.5%.

R&D Spending

Not reported for Q2 2026.

AVY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.2B	$8.9B+1.1%	$8.8B+4.7%	$8.4B-7.5%	$9.0B+7.5%	$8.4B+20.6%	$7.0B-1.4%	$7.1B-1.2%	$7.2B+8.2%	$6.6B+8.7%	$6.1B+2.0%	$6.0B-5.7%	$6.3B+3.1%	$6.1B+4.7%	$5.9B+0.3%	$5.8B
Cost of Revenue	$6.6B	$6.3B+1.4%	$6.2B+2.3%	$6.1B-8.3%	$6.6B+8.9%	$6.1B+20.7%	$5.0B-2.3%	$5.2B-1.5%	$5.2B+9.2%	$4.8B+9.5%	$4.4B+1.5%	$4.3B-7.7%	$4.7B+3.9%	$4.5B+3.9%	$4.3B-0.8%	$4.4B
Gross Profit	$2.7B	$2.5B+0.6%	$2.5B+11.1%	$2.3B-5.3%	$2.4B+4.0%	$2.3B+20.3%	$1.9B+1.0%	$1.9B-0.6%	$1.9B+5.7%	$1.8B+6.6%	$1.7B+3.3%	$1.6B-0.3%	$1.7B+0.8%	$1.6B+7.2%	$1.5B+3.6%	$1.5B
R&D Expenses	N/A	$136.6M-0.9%	$137.8M+1.5%	$135.8M-0.2%	$136.1M-0.4%	$136.6M+21.1%	$112.8M+21.8%	$92.6M-5.7%	$98.2M+5.1%	$93.4M+4.1%	$89.7M-2.4%	$91.9M-10.3%	$102.5M+6.8%	$96.0M-2.6%	$98.6M+5.1%	$93.8M
SG&A Expenses	$1.5B	$1.4B+0.5%	$1.4B+7.7%	$1.3B-1.3%	$1.3B+6.6%	$1.2B+17.7%	$1.1B-1.8%	$1.1B-4.2%	$1.1B+2.0%	$1.1B+1.8%	$1.1B-2.0%	$1.1B-4.4%	$1.2B-1.3%	$1.2B+2.2%	$1.1B+0.8%	$1.1B
Interest Expense	$142.0M	$135.4M+15.7%	$117.0M-1.7%	$119.0M+41.5%	$84.1M+19.8%	$70.2M+0.3%	$70.0M-7.7%	$75.8M+29.6%	$58.5M-7.1%	$63.0M+5.2%	$59.9M-1.0%	$60.5M-4.4%	$63.3M+3.9%	$60.9M-16.5%	$72.9M+2.5%	$71.1M
Income Tax	$260.8M	$237.1M-4.6%	$248.6M+29.7%	$191.7M-20.9%	$242.2M-2.6%	$248.6M+39.9%	$177.7M+413.4%	-$56.7M-166.4%	$85.4M-72.2%	$307.7M+96.7%	$156.4M+16.3%	$134.5M+18.5%	$113.5M-8.7%	$124.3M+55.4%	$80.0M+11.9%	$71.5M
Net Income	$704.9M	$688.0M-2.4%	$704.9M+40.1%	$503.0M-33.6%	$757.1M+2.3%	$740.1M+33.1%	$555.9M+83.1%	$303.6M-35.0%	$467.4M+65.9%	$281.8M-12.1%	$320.7M+16.9%	$274.3M+11.9%	$245.1M+15.0%	$213.2M-1.0%	$215.4M+13.3%	$190.1M
EPS (Basic)	N/A	$8.81+0.5%	$8.77+40.8%	$6.23-32.9%	$9.28+3.9%	$8.93+33.9%	$6.67+84.8%	$3.61-32.5%	$5.35+67.7%	$3.19-11.4%	$3.60+19.6%	$3.01+15.3%	$2.61+20.3%	$2.17+3.3%	$2.10+16.7%	$1.80
EPS (Diluted)	$9.13	$8.79+0.7%	$8.73+40.8%	$6.20-32.7%	$9.21+4.3%	$8.83+33.6%	$6.61+85.2%	$3.57-32.4%	$5.28+68.7%	$3.13-11.6%	$3.54+20.0%	$2.95+15.2%	$2.56+20.2%	$2.13+2.4%	$2.08+16.9%	$1.78
Diluted Shares (Avg)	N/A	78M-3.0%	81M-0.5%	81M-1.3%	82M-1.9%	84M-0.4%	84M-1.1%	85M-4.1%	89M-1.7%	90M-0.7%	91M-2.4%	93M-2.9%	96M-4.4%	100M-3.3%	104M-3.1%	107M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.5B+10.9%	$2.3B+7.0%	$2.3B+3.9%	$2.2B+1.5%	$2.2B-0.7%	$2.1B-0.1%	$2.2B+3.6%	$2.2B+4.1%
Cost of Revenue	$1.7B+9.6%	$1.6B+7.0%	$1.6B+2.8%	$1.6B+1.5%	$1.6B+0.6%	$1.5B+0.5%	$1.6B+4.1%	$1.6B+2.9%
Gross Profit	$729.4M+14.1%	$664.8M+7.0%	$650.7M+6.8%	$635.0M+1.3%	$639.1M-3.6%	$621.5M-1.7%	$609.2M+2.2%	$626.6M+7.0%
SG&A Expenses	$394.8M+12.0%	$375.1M+8.1%	$369.2M+12.1%	$353.9M+2.0%	$352.4M-5.8%	$347.0M-5.0%	$329.3M-1.7%	$346.9M+6.8%
Interest Expense	$35.9M+5.6%	$35.6M+15.2%	$37.2M+27.4%	$33.3M+11.0%	$34.0M+16.4%	$30.9M+8.0%	$29.2M-1.7%	$30.0M-3.2%
Income Tax	$78.6M+18.2%	$72.3M+19.1%	$41.4M-38.6%	$68.5M+18.9%	$66.5M+8.0%	$60.7M-2.1%	$67.4M+15.2%	$57.6M+24.4%
Net Income	$204.1M+8.0%	$168.1M+1.1%	$166.4M-4.4%	$166.3M-8.5%	$189.0M+6.9%	$166.3M-3.5%	$174.0M+21.6%	$181.7M+31.4%
EPS (Basic)	$2.67+10.3%	$2.19+4.3%	$2.170.0%	$2.13-5.8%	$2.42+10.5%	$2.10-1.9%	$2.17+22.6%	$2.26+31.4%
EPS (Diluted)	$2.67+10.8%	$2.18+4.3%	$2.15-0.9%	$2.13-5.3%	$2.41+10.6%	$2.09-1.9%	$2.17+22.6%	$2.25+31.6%
Diluted Shares (Avg)	76M-2.4%	77M-3.0%	N/A	78M-3.5%	78M-3.3%	79M-2.0%	N/A	81M-0.2%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

AVY Balance Sheet

AVY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$8.8B+4.7%	$8.4B+2.4%	$8.2B+3.3%	$8.0B-0.3%	$8.0B+31.0%	$6.1B+10.8%	$5.5B+6.0%	$5.2B+0.8%	$5.1B+16.8%	$4.4B+6.4%	$4.1B-5.1%	$4.4B-5.5%	$4.6B-9.7%	$5.1B+2.7%	$5.0B
Current Assets	$3.0B-2.9%	$3.1B+10.1%	$2.8B+0.5%	$2.8B+1.7%	$2.7B+13.2%	$2.4B+3.2%	$2.3B+1.9%	$2.3B+2.7%	$2.2B+17.5%	$1.9B+7.3%	$1.8B-7.6%	$1.9B-8.2%	$2.1B-13.3%	$2.4B+8.7%	$2.2B
Cash & Equivalents	$202.8M-38.4%	$329.1M+53.1%	$215.0M+28.6%	$167.2M+2.8%	$162.7M-35.5%	$252.3M-0.6%	$253.7M+9.4%	$232.0M+3.4%	$224.4M+15.0%	$195.1M+22.9%	$158.8M-23.4%	$207.2M-41.0%	$351.1M+49.2%	$235.4M+32.2%	$178.0M
Short-Term Investments	$49.1M+2.3%	$48.0M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$975.8M-0.2%	$978.1M+6.2%	$920.7M-8.8%	$1.0B+11.3%	$907.2M+26.5%	$717.2M+8.2%	$663.0M+1.8%	$651.4M+6.9%	$609.6M+17.4%	$519.1M+8.4%	$478.7M-2.7%	$491.8M-0.5%	$494.1M+4.4%	$473.3M-0.4%	$475.1M
Accounts Receivable	$1.5B+2.6%	$1.5B+3.6%	$1.4B+2.9%	$1.4B-3.5%	$1.4B+15.3%	$1.2B+1.9%	$1.2B+1.9%	$1.2B+0.8%	$1.2B+17.9%	$1.0B+3.8%	$964.7M+0.7%	$958.1M-5.7%	$1.0B+4.5%	$972.8M+10.9%	$877.1M
Long-Term Investments	$1.1M-86.9%	$8.4M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.3B+15.0%	$2.0B-1.9%	$2.0B+8.1%	$1.9B-1.0%	$1.9B+65.6%	$1.1B+22.1%	$930.8M-1.2%	$941.8M-4.4%	$985.1M+24.1%	$793.6M+15.7%	$686.2M-4.9%	$721.6M-4.9%	$758.5M-0.8%	$764.4M+0.7%	$759.3M
Total Liabilities	$6.6B+7.7%	$6.1B+0.2%	$6.1B+2.8%	$5.9B-2.1%	$6.0B+31.5%	$4.6B+7.3%	$4.3B+1.5%	$4.2B+2.9%	$4.1B+18.3%	$3.5B+9.6%	$3.2B-4.3%	$3.3B+5.3%	$3.1B-11.9%	$3.6B+7.7%	$3.3B
Current Liabilities	$2.7B-7.3%	$2.9B+6.0%	$2.7B-3.6%	$2.8B+9.9%	$2.5B+32.3%	$1.9B-14.5%	$2.3B+13.0%	$2.0B+1.1%	$2.0B-1.6%	$2.0B+37.4%	$1.5B-8.4%	$1.6B+2.5%	$1.6B-25.1%	$2.1B+25.9%	$1.6B
Non-Current Liabilities	$3.9B+21.0%	$3.2B-4.5%	$3.4B+8.5%	$3.1B-10.9%	$3.5B+30.9%	$2.7B+31.6%	$2.0B-8.9%	$2.2B+4.5%	$2.1B+45.4%	$1.5B-14.2%	$1.7B-0.4%	$1.7B+8.0%	$1.6B+6.3%	$1.5B-10.4%	$1.7B
Long-Term Debt	$3.2B+25.4%	$2.6B-2.4%	$2.6B+4.7%	$2.5B-10.1%	$2.8B+35.8%	$2.1B+36.9%	$1.5B-15.4%	$1.8B+34.6%	$1.3B+84.5%	$713.4M-26.0%	$963.6M+2.5%	$940.1M-1.1%	$950.6M+35.4%	$702.2M-26.4%	$954.2M
Total Equity	$2.2B-3.0%	$2.3B+8.7%	$2.1B+4.7%	$2.0B+5.6%	$1.9B+29.6%	$1.5B+23.3%	$1.2B+26.1%	$955.1M-7.5%	$1.0B+11.6%	$925.5M-4.2%	$965.7M-7.8%	$1.0B-28.6%	$1.5B-4.5%	$1.5B-7.4%	$1.7B
Retained Earnings	$5.6B+8.7%	$5.2B+9.8%	$4.7B+6.3%	$4.4B+13.8%	$3.9B+15.9%	$3.3B+12.4%	$3.0B+4.0%	$2.9B+10.3%	$2.6B+5.0%	$2.5B+8.6%	$2.3B+7.6%	$2.1B+5.3%	$2.0B+5.1%	$1.9B+5.5%	$1.8B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$9.2B+7.5%	$9.0B+7.5%	$8.8B+4.7%	$8.9B+4.9%	$8.6B+3.3%	$8.4B+1.2%	$8.4B+2.4%	$8.5B+3.9%
Current Assets	$3.4B+6.8%	$3.2B+6.2%	$3.0B-2.9%	$3.5B+14.2%	$3.2B+7.3%	$3.0B+5.0%	$3.1B+10.1%	$3.1B+9.6%
Cash & Equivalents	$227.3M+5.3%	$255.1M+30.2%	$202.8M-38.4%	$536.3M+152.1%	$215.9M+3.4%	$195.9M+5.5%	$329.1M+53.1%	$212.7M+1.3%
Short-Term Investments	$0	$0	$49.1M+2.3%	$0	$0	$0	$48.0M	$0
Inventory	$1.0B+0.5%	$989.4M-2.8%	$975.8M-0.2%	$1.0B+2.4%	$1.0B+4.8%	$1.0B+4.6%	$978.1M+6.2%	$1.0B+8.3%
Accounts Receivable	$1.8B+10.3%	$1.6B+8.5%	$1.5B+2.6%	$1.6B+3.4%	$1.6B+6.4%	$1.5B+2.7%	$1.5B+3.6%	$1.6B+10.4%
Long-Term Investments	$400K	$700K	$1.1M-86.9%	$0	$0	$0	$8.4M	$0
Goodwill	$2.3B+11.5%	$2.3B+13.6%	$2.3B+15.0%	$2.0B+0.8%	$2.0B+1.9%	$2.0B-0.1%	$2.0B-1.9%	$2.0B+1.8%
Total Liabilities	$6.9B+8.2%	$6.7B+8.0%	$6.6B+7.7%	$6.7B+9.9%	$6.4B+5.9%	$6.2B+2.2%	$6.1B+0.2%	$6.1B-0.2%
Current Liabilities	$3.0B-1.9%	$2.8B-5.2%	$2.7B-7.3%	$2.8B-16.8%	$3.1B-7.2%	$3.0B-10.7%	$2.9B+6.0%	$3.3B+22.0%
Non-Current Liabilities	$3.9B+17.6%	$3.9B+20.0%	$3.9B+21.0%	$3.9B+42.8%	$3.3B+21.9%	$3.2B+17.8%	$3.2B-4.5%	$2.7B-18.5%
Long-Term Debt	$3.2B+20.9%	$3.2B+23.4%	$3.2B+25.4%	$3.2B+56.8%	$2.6B+28.4%	$2.6B+24.7%	$2.6B-2.4%	$2.0B-21.4%
Total Equity	$2.3B+5.5%	$2.3B+6.0%	$2.2B-3.0%	$2.2B-7.6%	$2.2B-3.7%	$2.2B-1.5%	$2.3B+8.7%	$2.4B+16.0%
Retained Earnings	$5.8B+8.2%	$5.7B+8.2%	$5.6B+8.7%	$5.5B+9.0%	$5.4B+9.7%	$5.3B+9.7%	$5.2B+9.8%	$5.0B+9.4%

AVY Cash Flow Statement

AVY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.2B	$881.4M-6.1%	$938.8M+13.7%	$826.0M-14.0%	$961.0M-8.2%	$1.0B+39.3%	$751.3M+0.6%	$746.5M+63.0%	$457.9M-29.1%	$645.7M+10.9%	$582.1M+22.9%	$473.7M+33.5%	$354.9M+11.0%	$319.6M-37.7%	$513.4M+21.5%	$422.7M
Depreciation & Amortization	N/A	$328.2M+5.1%	$312.2M+4.6%	$298.4M+2.6%	$290.7M+19.1%	$244.1M+18.9%	$205.3M+14.7%	$179.0M-1.1%	$181.0M+1.3%	$178.7M-0.8%	$180.1M-4.4%	$188.3M-6.6%	$201.6M-1.3%	$204.3M-3.2%	$211.0M-4.1%	$220.0M
Stock-Based Compensation	N/A	$27.9M-2.8%	$28.7M+28.7%	$22.3M-53.0%	$47.4M+27.4%	$37.2M+55.0%	$24.0M-30.4%	$34.5M+0.6%	$34.3M+13.6%	$30.2M+11.0%	$27.2M+3.4%	$26.3M-7.1%	$28.3M-16.8%	$34.0M-12.6%	$38.9M-1.8%	$39.6M
Capital Expenditures	$170.5M	$169.0M-19.1%	$208.8M-21.3%	$265.3M-4.6%	$278.1M+9.1%	$255.0M+26.6%	$201.4M-8.2%	$219.4M-3.2%	$226.7M+19.0%	$190.5M+7.7%	$176.9M+30.3%	$135.8M-8.2%	$147.9M+14.5%	$129.2M+30.2%	$99.2M-9.5%	$109.6M
Free Cash Flow	$1.1B	$712.4M-2.4%	$730.0M+30.2%	$560.7M-17.9%	$682.9M-13.8%	$791.8M+44.0%	$549.9M+4.3%	$527.1M+128.0%	$231.2M-49.2%	$455.2M+12.3%	$405.2M+19.9%	$337.9M+63.2%	$207.0M+8.7%	$190.4M-54.0%	$414.2M+32.3%	$313.1M
Investing Cash Flow	-$685.2M	-$596.0M-145.2%	-$243.1M+47.0%	-$459.0M-38.0%	-$332.7M+80.9%	-$1.7B-213.6%	-$554.2M-120.8%	-$251.0M-8.0%	-$232.5M+57.2%	-$543.3M-25.7%	-$432.2M-202.4%	-$142.9M+16.1%	-$170.4M-150.2%	$339.4M+312.1%	-$160.0M-53.6%	-$104.2M
Financing Cash Flow	-$536.0M	-$414.9M+28.0%	-$576.1M-81.6%	-$317.2M+48.4%	-$615.2M-201.8%	$604.3M+390.9%	-$207.7M+55.8%	-$470.3M-126.0%	-$208.1M-148.0%	-$83.9M+21.0%	-$106.2M+71.1%	-$367.3M-13.5%	-$323.5M+40.8%	-$546.2M-83.5%	-$297.6M-9.6%	-$271.5M
Dividends Paid	$294.0M	$288.4M+3.9%	$277.5M+8.1%	$256.7M+7.5%	$238.9M+8.3%	$220.6M+12.1%	$196.8M+3.7%	$189.7M+8.4%	$175.0M+12.5%	$155.5M+9.1%	$142.5M+7.1%	$133.1M+6.4%	$125.1M+11.7%	$112.0M+1.4%	$110.4M+3.7%	$106.5M
Share Buybacks	$410.5M	$572.3M+131.2%	$247.5M+80.0%	$137.5M-63.8%	$379.5M+109.8%	$180.9M+73.4%	$104.3M-56.1%	$237.7M-39.5%	$392.9M+202.9%	$129.7M-50.6%	$262.4M+13.0%	$232.3M-34.7%	$355.5M+25.4%	$283.5M+20.5%	$235.2M+1642.2%	$13.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$408.2M+95.5%	$136.5M+937.4%	$376.8M+7.3%	$312.1M+15.5%	$208.8M+5.6%	-$16.3M-113.6%	$351.2M+12.6%	$270.1M-16.3%
Depreciation & Amortization	$86.4M+6.9%	$86.8M+11.4%	$85.5M+9.3%	$84.0M+7.6%	$80.8M+2.8%	$77.9M+0.8%	$78.2M-18.3%	$78.1M+13.0%
Stock-Based Compensation	N/A	$5.8M-26.6%	N/A	N/A	N/A	$7.9M+5.3%	N/A	N/A
Capital Expenditures	$39.2M+30.7%	$28.3M-21.4%	$67.1M-3.5%	$35.9M-16.5%	$30.0M-36.8%	$36.0M-26.2%	$69.5M-24.7%	$43.0M-24.7%
Free Cash Flow	$369.0M+106.4%	$108.2M+306.9%	$309.7M+9.9%	$276.2M+21.6%	$178.8M+19.0%	-$52.3M-173.7%	$281.7M+28.3%	$227.1M-14.5%
Investing Cash Flow	-$117.8M-320.7%	-$32.6M+1.8%	-$491.4M-567.7%	-$43.4M+14.4%	-$28.0M+50.7%	-$33.2M+46.5%	-$73.6M+35.9%	-$50.7M-127.4%
Financing Cash Flow	-$319.0M-95.0%	-$50.6M+40.4%	-$219.3M-40.3%	$52.9M+124.3%	-$163.6M-39.7%	-$84.9M+0.1%	-$156.3M+19.6%	-$217.7M+28.8%
Dividends Paid	$76.2M+3.7%	$72.3M+4.2%	$72.4M+2.8%	$73.1M+3.1%	$73.5M+3.7%	$69.4M+6.3%	$70.4M+8.0%	$70.9M+8.6%
Share Buybacks	$137.6M+39.8%	$60.6M-76.8%	$118.7M-15.2%	$93.6M+40.1%	$98.4M+292.0%	$261.6M+1576.9%	$140.0M+586.3%	$66.8M+142.0%

AVY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	28.7%-0.2pp	28.9%+1.7pp	27.2%+0.6pp	26.6%-0.9pp	27.5%-0.1pp	27.6%+0.7pp	26.9%+0.2pp	26.8%-0.6pp	27.4%-0.5pp	27.9%+0.4pp	27.6%+1.5pp	26.1%-0.6pp	26.7%+0.6pp	26.1%+0.8pp	25.2%
Net Margin	7.8%-0.3pp	8.1%+2.0pp	6.0%-2.4pp	8.4%-0.4pp	8.8%+0.8pp	8.0%+3.7pp	4.3%-2.2pp	6.5%+2.3pp	4.3%-1.0pp	5.3%+0.7pp	4.6%+0.7pp	3.9%+0.4pp	3.5%-0.2pp	3.7%+0.4pp	3.3%
Return on Equity	30.7%+0.2pp	30.5%+6.8pp	23.6%-13.6pp	37.3%-1.2pp	38.5%+1.0pp	37.4%+12.2pp	25.2%-23.7pp	48.9%+21.6pp	27.3%-7.3pp	34.6%+6.3pp	28.4%+5.0pp	23.4%+8.9pp	14.5%+0.5pp	14.0%+2.6pp	11.5%
Return on Assets	7.8%-0.6pp	8.4%+2.3pp	6.1%-3.4pp	9.5%+0.2pp	9.3%+0.1pp	9.1%+3.6pp	5.5%-3.5pp	9.0%+3.5pp	5.5%-1.8pp	7.3%+0.7pp	6.6%+1.0pp	5.6%+1.0pp	4.6%+0.4pp	4.2%+0.4pp	3.8%
Current Ratio	1.13+0.1x	1.080.0x	1.040.0x	0.99-0.1x	1.07-0.2x	1.25+0.2x	1.04-0.1x	1.150.0x	1.14+0.2x	0.95-0.3x	1.220.0x	1.21-0.1x	1.35+0.2x	1.16-0.2x	1.35
Debt-to-Equity	1.43+0.3x	1.11-0.1x	1.230.0x	1.23-0.2x	1.45+0.1x	1.38+0.1x	1.25-0.6x	1.85+0.6x	1.27+0.5x	0.77-0.2x	1.00+0.1x	0.90+0.2x	0.65+0.2x	0.46-0.1x	0.58
Asset Turnover	1.010.0x	1.040.0x	1.02-0.1x	1.14+0.1x	1.05-0.1x	1.15-0.1x	1.29-0.1x	1.38+0.1x	1.29-0.1x	1.38-0.1x	1.440.0x	1.45+0.1x	1.33+0.2x	1.150.0x	1.18
FCF Margin	8.0%-0.3pp	8.3%+1.6pp	6.7%-0.8pp	7.5%-1.9pp	9.4%+1.5pp	7.9%+0.4pp	7.5%+4.2pp	3.2%-3.6pp	6.9%+0.2pp	6.7%+1.0pp	5.7%+2.4pp	3.3%+0.2pp	3.1%-4.0pp	7.1%+1.7pp	5.4%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	29.6%+0.8pp	28.9%0.0pp	28.6%+0.8pp	28.7%0.0pp	28.8%-0.9pp	28.9%-0.5pp	27.9%-0.4pp	28.7%+0.8pp
Net Margin	8.3%-0.2pp	7.3%-0.4pp	7.3%-0.6pp	7.5%-0.8pp	8.5%+0.6pp	7.7%-0.3pp	8.0%+1.2pp	8.3%+1.7pp
Return on Equity	8.8%+0.2pp	7.3%-0.4pp	7.4%-0.1pp	7.5%-0.1pp	8.6%+0.9pp	7.7%-0.2pp	7.5%+0.8pp	7.6%+0.9pp
Return on Assets	2.2%0.0pp	1.9%-0.1pp	1.9%-0.2pp	1.9%-0.3pp	2.2%+0.1pp	2.0%-0.1pp	2.1%+0.3pp	2.1%+0.4pp
Current Ratio	1.13+0.1x	1.15+0.1x	1.13+0.1x	1.26+0.3x	1.04+0.1x	1.03+0.2x	1.080.0x	0.92-0.1x
Debt-to-Equity	1.37+0.2x	1.38+0.2x	1.43+0.3x	1.45+0.6x	1.19+0.3x	1.19+0.3x	1.11-0.1x	0.85-0.4x
Asset Turnover	0.270.0x	0.260.0x	0.260.0x	0.250.0x	0.260.0x	0.260.0x	0.260.0x	0.260.0x
FCF Margin	15.0%+6.9pp	4.7%+7.1pp	13.6%+0.8pp	12.5%+2.1pp	8.1%+1.3pp	-2.4%-5.7pp	12.9%+2.5pp	10.4%-2.3pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Avery Dennison Corp. AVY	FY2025	$8.9B	$688.0M	7.8%	$12.7B	27/100
Ball Corporation BALL	FY2025	$13.2B	$915.0M	7.0%	$15.5B	51/100
Crown Holdings Inc. CCK	FY2025	$12.4B	$738.0M	6.0%	$11.8B	51/100
Smurfit Westrock plc SW	FY2025	$31.2B	$699.0M	2.2%	$21.7B	50/100
Packaging Corp of America PKG	FY2025	$9.0B	$774.1M	8.6%	$20.5B	64/100
Amcor plc AMCR	FY2026	$23.5B	$1.1B	4.7%	$19.3B	52/100

Where Avery Dennison Corp. Ranks

Frequently Asked Questions

What is Avery Dennison Corp.'s annual revenue?

Avery Dennison Corp. (AVY) reported $8.9B in total revenue for fiscal year 2025. This represents a 1.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Avery Dennison Corp.'s revenue growing?

Avery Dennison Corp. (AVY) revenue grew by 1.1% year-over-year, from $8.8B to $8.9B in fiscal year 2025.

Is Avery Dennison Corp. profitable?

Yes, Avery Dennison Corp. (AVY) reported a net income of $688.0M in fiscal year 2025, with a net profit margin of 7.8%.

How much debt does Avery Dennison Corp. have?

As of fiscal year 2025, Avery Dennison Corp. (AVY) had $202.8M in cash and equivalents against $3.2B in long-term debt.

What is Avery Dennison Corp.'s gross margin?

Avery Dennison Corp. (AVY) had a gross margin of 28.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Avery Dennison Corp.'s net profit margin?

Avery Dennison Corp. (AVY) had a net profit margin of 7.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Avery Dennison Corp. pay dividends?

Yes, Avery Dennison Corp. (AVY) paid $3.70 per share in dividends during fiscal year 2025.

What is Avery Dennison Corp.'s return on equity (ROE)?

Avery Dennison Corp. (AVY) has a return on equity of 30.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Avery Dennison Corp.'s free cash flow?

Avery Dennison Corp. (AVY) generated $712.4M in free cash flow during fiscal year 2025. This represents a -2.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Avery Dennison Corp.'s operating cash flow?

Avery Dennison Corp. (AVY) generated $881.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Avery Dennison Corp.'s total assets?

Avery Dennison Corp. (AVY) had $8.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Avery Dennison Corp.'s capital expenditures?

Avery Dennison Corp. (AVY) invested $169.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Avery Dennison Corp. spend on research and development?

Avery Dennison Corp. (AVY) invested $136.6M in research and development during fiscal year 2025.

Does Avery Dennison Corp. buy back shares?

Yes, Avery Dennison Corp. (AVY) spent $572.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Avery Dennison Corp. have outstanding?

Avery Dennison Corp. (AVY) had 77M shares outstanding as of fiscal year 2025.

What is Avery Dennison Corp.'s current ratio?

Avery Dennison Corp. (AVY) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.

What is Avery Dennison Corp.'s debt-to-equity ratio?

Avery Dennison Corp. (AVY) had a debt-to-equity ratio of 1.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Avery Dennison Corp.'s return on assets (ROA)?

Avery Dennison Corp. (AVY) had a return on assets of 7.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Avery Dennison Corp.'s P/E ratio?

Avery Dennison Corp. (AVY) trades at 18.0x earnings, its market capitalization divided by net income of $704.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $12.7B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Avery Dennison Corp.'s price-to-sales ratio?

Avery Dennison Corp. (AVY) trades at 1.4x sales, its market capitalization divided by revenue of $9.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $12.7B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Avery Dennison Corp.'s Piotroski F-Score?

Avery Dennison Corp. (AVY) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Avery Dennison Corp.'s earnings high quality?

Avery Dennison Corp. (AVY) has an earnings quality ratio of 1.28x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Avery Dennison Corp.?

Avery Dennison Corp. (AVY) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.